Therapeutic Variables in Cataract Surgery

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Cataract Surgery

Treatments: Drug: Moxifloxacin; Drug: Pred Forte; Drug: Nepafenac; Drug: EconoPred Plus; Drug: Gatifloxacin; Drug: Ketorolac LS

Study type: Interventional

Funder types: Industry

Identifiers

NCT00407017

5264-T

Details and patient eligibility

About

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males or females scheduled to undergo cataract surgery
• Patients can be receiving monofocal IOLs only
• Likely to complete all study visits and able to provide informed consent
• Visual potential of 20/25 or better

Exclusion criteria

• Known contraindications to any study medication or ingredients
• Active ocular diseases or uncontrolled systemic disease
• Active ocular allergies